Bimodal Fluorescence/{129}Xe NMR Probe for Molecular Imaging and Biological Inhibition of EGFR in Non-Small Cell Lung Cancer - CEA - Commissariat à l’énergie atomique et aux énergies alternatives Access content directly
Journal Articles Bioorganic and Medicinal Chemistry Year : 2017

Bimodal Fluorescence/{129}Xe NMR Probe for Molecular Imaging and Biological Inhibition of EGFR in Non-Small Cell Lung Cancer

Gaëlle Milanole
  • Function : Author
  • PersonId : 771606
  • IdRef : 175082669
Bo Gao
Thierry Brotin

Abstract

Although Non-Small Cell Lung Cancer (NSCLC) is one of the main causes of cancer death, very little improvement has been made in the last decades regarding diagnosis and outcomes. In this study, a bimodal fluorescence/$^{129}$Xe NMR probe containing a xenon host, a fluorescent moiety and a therapeutic antibody has been designed to target the Epidermal Growth Factor Receptors (EGFR) overexpressed in cancer cells. This biosensor shows high selectivity for the EGFR, and a biological activity similar to that of the antibody. It is detected with high specificity and high sensitivity (sub-nanomolar range) through hyperpolarized $^{129}$Xe NMR. This promising system should find important applications for theranostic use.
Fichier principal
Vignette du fichier
Milanole_BioMedChem2017_V0.pdf (649.63 Ko) Télécharger le fichier
Origin : Files produced by the author(s)
Loading...

Dates and versions

cea-01630103 , version 1 (07-11-2017)

Identifiers

Cite

Gaëlle Milanole, Bo Gao, Audrey Paoletti, Grégory Pieters, Christophe Dugave, et al.. Bimodal Fluorescence/{129}Xe NMR Probe for Molecular Imaging and Biological Inhibition of EGFR in Non-Small Cell Lung Cancer. Bioorganic and Medicinal Chemistry, 2017, 25, pp.6653-6660. ⟨10.1016/j.bmc.2017.11.002⟩. ⟨cea-01630103⟩
311 View
330 Download

Altmetric

Share

Gmail Facebook X LinkedIn More